Cited by 34Microtubule and mitosis dynamicsGenomic variations and chromosomal abnormalitiesCancer Genomics and Diagnostics

Karyotypic Aberrations in Oncogenesis and Cancer Therapy

Vitale, Ilio, Manic, Gwenola, Senovilla, Laura, Kroemer, Guido, Galluzzi, Lorenzo·2015·Trends in Cancer

Abstract

The propagation of whole-chromosome (aneuploid) or whole-genome (polyploid) defects is normally prevented by robust cell-intrinsic mechanisms. Moreover, non-diploid cells are under strict immunological surveillance. Nonetheless, tumors contain a high percentage of non-diploid genomes, indicating that malignant cells acquire the ability to bypass these control mechanisms and obtain a survival/proliferation benefit from bulky karyotypic defects. The non-diploid state imposes a significant metabolic burden on cancer cells and hence can be selectively targeted for therapeutic purposes. Here we discuss the impact of abnormal karyotypes on oncogenesis, tumor progression, and response to treatment, focusing on the biochemical and metabolic liabilities of non-diploid cells that can be harnessed for the development of novel chemo(immuno)therapeutic regimens against cancer.

Integrity signals

Registry

Crossref · 10.1016/j.trecan.2015.08.001

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 96 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Vitale, I., Manic, G., Senovilla, L., Kroemer, G., & Galluzzi, L.
Affiliations
  • University of Rome Tor Vergata (IT)
  • Instituto Nazionale Tumori Regina Elena (IT)
  • Inserm (FR)
  • Karolinska University Hospital (SE)
Corresponding author
Galluzzi, Lorenzo
Venue
Trends in Cancer
Publisher
Elsevier BV
Published
2015-10
Volume
1
Issue
2
Pages
124-135
ISSN
  • 2405-8025 (ISSN-L)
  • 2405-8033
OpenAlex
W1863134146
Cited by
34
References
96
Citations by year
2025: 4 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 5 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 10 · 2016: 3
FWCI
0.57
Type
journal article
Language
en
Open access
closed
Locations
  • Trends in cancer (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
aneuploidy, polyploidy, carcinogenesis, tumor progression, cancer therapy, cancer metabolism, metabolic liability, tumor surveillance, chemoimmunotherapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review